Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAT4 Gel for the reduction of nasolabial folds
NCT02607670Phase 2Unknown
- Sponsor
- Topokine Therapeutics
- Start
- Jan 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tafluprost in nasolabial folds, sponsored by Topokine Therapeutics. Status: unknown.
02
Drugs
tafluprost
03
Conditions
nasolabial folds
Beyond the preview
Go deeper on NCT02607670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607670.